Bijuva 1 mg / 100 mg
As listed in the register: Bijuva 1 mg / 100 mg, capsule molle
1 mg + 100 mg ·
- Prescription only
- Urinary and reproductive system, hormones
- Active substance
- Estradiolum + Progesteronum
- Made by
- Labatec Pharma SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Traitement hormonal substitutif post-ménopausique
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Labatec Pharma SA |
|---|---|
| Active substance | Estradiolum + Progesteronum |
| Used in | Urinary and reproductive system, hormones |
| Strength | 1 mg + 100 mg |
| Classification | G03FA04 · Urinary and reproductive system, hormones |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Bijuva 1 mg / 100 mg, capsule molle |
| Packs | 28 Kapsel(n) |
| Zulassungsnummer | 68971 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.